Consist with the previous study, treatment with downregulation of DKK-3 facilitated malignant phenotypes of prostate cancer cells, upregulating MMP-2 and MMP-9, and even reversed the effect caused by overexpression of LINC00261. Here, LINC00261 is linked to prostate carcinoma.